- Home
- RDZN vs CRVO Comparison
RDZN vs CRVO Comparison
Compare RDZN & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- CRVO
- Stock Information
- Founded
- RDZN 2015
- CRVO 2001
- Country
- RDZN United States
- CRVO United States
- Employees
- RDZN N/A
- CRVO N/A
- Industry
- RDZN Blank Checks
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- RDZN Finance
- CRVO Health Care
- Exchange
- RDZN Nasdaq
- CRVO Nasdaq
- Market Cap
- RDZN 75.2M
- CRVO 71.1M
- IPO Year
- RDZN N/A
- CRVO N/A
- Fundamental
- Price
- RDZN $1.31
- CRVO $8.43
- Analyst Decision
- RDZN Strong Buy
- CRVO Strong Buy
- Analyst Count
- RDZN 1
- CRVO 6
- Target Price
- RDZN $4.00
- CRVO $21.50
- AVG Volume (30 Days)
- RDZN 549.9K
- CRVO 68.6K
- Earning Date
- RDZN 11-14-2025
- CRVO 11-10-2025
- Dividend Yield
- RDZN N/A
- CRVO N/A
- EPS Growth
- RDZN N/A
- CRVO N/A
- EPS
- RDZN N/A
- CRVO N/A
- Revenue
- RDZN $48,035,296.00
- CRVO $6,159,786.00
- Revenue This Year
- RDZN $38.45
- CRVO N/A
- Revenue Next Year
- RDZN $66.38
- CRVO N/A
- P/E Ratio
- RDZN N/A
- CRVO N/A
- Revenue Growth
- RDZN 3.42
- CRVO N/A
- 52 Week Low
- RDZN $0.68
- CRVO $1.80
- 52 Week High
- RDZN $2.99
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- RDZN 47.81
- CRVO 61.68
- Support Level
- RDZN $1.32
- CRVO $7.11
- Resistance Level
- RDZN $1.50
- CRVO $7.80
- Average True Range (ATR)
- RDZN 0.19
- CRVO 0.49
- MACD
- RDZN -0.04
- CRVO 0.16
- Stochastic Oscillator
- RDZN 11.76
- CRVO 80.05
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.